D. E. Shaw & Co »

Bright Minds Biosciences shares owned by D. E. Shaw & Co

Quarter-by-quarter ownership of Bright Minds Biosciences (DRUG) shares owned by D. E. Shaw & Co from 13F filings

Historical chart of D. E. Shaw & Co investment in Bright Minds Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Bright Minds Biosciences held by D. E. Shaw & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bright Minds Biosciences by D. E. Shaw & Co

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.1M 15k 72.97
2025-12-31 $306k 3.9k 78.04

More positions owned by D. E. Shaw & Co

NVIDIA Corporation (NVDA)
Microsoft Corporation Put Option (MSFT)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom Call Option (AVGO)
Apple Put Option (AAPL)
Alphabet Cap Stk Cl C Call Option (GOOG)
Micron Technology Put Option (MU)
Meta Platforms Cl A Call Option (META)
Amazon (AMZN)
Boston Scientific Corporation Call Option (BSX)
Advanced Micro Devices Put Option (AMD)
Taiwan Semiconductor Manufac Sponsored Ads Call Option (TSM)
JPMorgan Chase & Co. Call Option (JPM)
Palantir Technologies Cl A Call Option (PLTR)

View all positions for D. E. Shaw & Co

Top funds holding Bright Minds Biosciences

Henderson Group
Cormorant Asset Management
BlackRock
Vivo Capital
Braidwell
Vestal Point Capital
Adage Capital Partners GP
Perceptive Advisors
Balyasny Asset Management
Deerfield Management Company
Driehaus Capital Management
RA Capital Management
Dr. Jeffrey R. Jay, M.D.
MPM Oncology Impact Management
Ikarian Capital

View all funds holding Bright Minds Biosciences